We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

DRUG DISCOUNT CARD MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Drug Discount Card Market, By Type (Branded Cards and Generic Cards), By Therapeutic Category (Cardiovascular drugs, Diabetes drugs, Pain medications, Mental health medications, Cancer drugs, and Others), By Sales Channel (Online and Offline), , By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Nov 2023
  • Code : CMI6283
  • Pages :140
  • Formats :
      Excel and PDF
  • Industry : Healthcare IT

Drug Discount Card Market Size and Trends

The Drug Discount Card Market size was valued at US$ 1,674.2 Million in 2023 and is expected to reach US$ 2,894.4 Million by 2030, growing at a compound annual growth rate (CAGR) of 8.1% from 2023 to 2030. Drug discount cards, also known as prescription drug discount cards or pharmacy savings cards, are a popular and cost-effective way for consumers to reduce their out-of-pocket expenses on prescription medications. These cards are typically distributed by various entities, including pharmaceutical companies, independent card providers, non-profit organizations, and government programs, with the primary aim of providing discounts on the purchase of prescription drugs. These cards work by negotiating lower prices for medications with participating pharmacies and passing the savings on to the cardholders. They are not insurance but serve as a supplementary tool to help individuals, especially those without comprehensive health insurance coverage, access necessary medications at a more affordable cost.

Drug Discount Card Market Trends:

  • Adoption of Data Analytics: The adoption of big data analytics is an important trend impacting the drug discount card market. Companies are utilizing advanced data analytics to gain insights on prescription fill patterns, medications with highest spend, and savings opportunities. This data enables the development of targeted programs, providing maximum savings on high cost therapy areas. Data analytics also allows measuring program returns on investment (ROI) for pharmaceutical partners. For instance, a discount platform uses real-world data and analytics on doctors' prescribing patterns to create personalized prescription savings programs. The trend of leveraging data and analytics will continue allowing value enhancements.
  • Shift to Value-based Care: The shift from fee-for-service to value-based care models is an important trend. This transition places emphasis on improving outcomes and lowering treatment costs. As part of this, healthcare systems are integrating outpatient prescription drug benefits into bundled payments contracts. Prescription discount cards allow systems to reduce pharmacy benefit costs passed onto patients. Leading cards are being built into IT systems enabling use during point-of-care. Increased adoption by health systems to lower outpatient prescription costs for superior population health management is a key trend.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.